(Natural News) Lawmakers found that executives of a company contracted for manufacturing Wuhan coronavirus (COVID-19) vaccines covered up quality control issues in one of its factories. Two Congressional committees made this discovery via a report published on May 10, which scrutinized vaccine manufacturer Emergent BioSolutions. According to the document, inexperienced staff and high turnover rates […]

(Natural News) U.S.-based drugmaker Moderna Inc. said on April 16 that it will deliver fewer coronavirus (COVID-19) vaccines than planned to countries outside the U.S., citing issues with its European supply chain. The pharmaceutical and biotechnology company said the shortfall in doses affects expected deliveries for the second quarter in a number of countries but didn’t […]

(Natural News) The Chinese government defended widespread immunizations against COVID-19 outside of clinical trials in the country. The vaccinations were warranted, as there were no documented side effects from the experimental vaccines, and imported COVID-19 cases proved to be a serious risk to the country. Chinese National Health Commission director for coronavirus vaccine development Zheng […]

(Natural News) A memorandum of understanding between British pharmaceutical company AstraZeneca and Brazilian public health research institution Fiocruz obtained by The Financial Times stated the drugmaker has the right to declare the pandemic’s end by July 2021. Under the document’s terms, AstraZeneca will also be providing doses of its coronavirus vaccine – developed in tandem with […]

(Natural News) China has promised to fast-track the development of an effective coronavirus vaccine before the year ends and share this vaccine with other countries as part of its contribution to the fight against COVID-19. However, some have questioned China’s capability to produce sufficient doses. They also raised concerns with the country’s deals with individual nations. […]

(Natural News) As many as 100 million coronavirus vaccines could be ready for distribution as early as October, according to the White House. Speaking to reporters on Sept. 17, White House Chief of Staff Mark Meadows said that the initial tranche of 100 million vaccines would be sent to individuals with the highest risk of […]